Vertex Pharmaceuticals Inc / Ma SEC filings VRTX
Vertex Pharmaceuticals Inc / Ma has 1,002 filings in SEC EDGAR's recent list, going back to Jun 3, 2020. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 20, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 1, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Jul 7, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Results of operations
|
May 4, 2026 | May 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Other events
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 12, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Other events
|
May 19, 2025 | May 19, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations
|
May 5, 2025 | May 5, 2025 |
| 8-K |
Current report
Other events
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 10, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 20, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Material agreement
|
Aug 16, 2024 | Aug 15, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Other events
|
May 20, 2024 | May 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 11, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 5, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Other events
|
Dec 8, 2023 | Dec 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 5, 2023 | Dec 5, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 5, 2023 | Oct 3, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2023 | Aug 1, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 18, 2023 | May 17, 2023 |
| 8-K |
Current report
Results of operations
|
May 1, 2023 | May 1, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 7, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2022 | Oct 27, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Other events
|
Jul 11, 2022 | Jul 9, 2022 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Jul 5, 2022 | Jul 1, 2022 |
| 8-K |
Current report
Other events
|
May 23, 2022 | May 23, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 18, 2022 | May 18, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 26, 2022 | Jan 26, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2021 | Nov 2, 2021 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2021 | Jul 29, 2021 |
| 8-K |
Current report
Other events
|
Jun 24, 2021 | Jun 23, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2021 | May 19, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2021 | Apr 29, 2021 |
| 8-K |
Current report
Material agreement
|
Apr 20, 2021 | Apr 16, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 1, 2021 | Feb 1, 2021 |
| 8-K |
Current report
Other events
|
Nov 20, 2020 | Nov 20, 2020 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2020 | Oct 29, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 21, 2020 | Sep 18, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2020 | Jun 3, 2020 |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VRTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- MA
- Headquarters
- Boston, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 875320
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.